Telefónica is set to unveil groundbreaking healthcare innovations at the upcoming Mobile World Congress (MWC), leveraging 5G connectivity, edge computing, and Artificial Intelligence (AI). The telecom giant will highlight two transformative projects designed to improve medical diagnostics and patient monitoring:
- “CatEye” – A smart, portable device that uses 5G and AI to assess cataract severity and determine the need for surgery.
- “5G Intelligent Blood Monitoring” – A real-time blood analysis system for cancer patients, reducing hospital visits and infection risks.
Revolutionizing Cataract Detection with “CatEye”
In collaboration with Edgendria Innovacion, Telefónica has developed “CatEye,” a 5G-enabled ophthalmic assessment tool. The device autonomously captures high-resolution eye images using precision servomotors and transmits them over 5G to an AI-driven platform, which determines whether surgical intervention is required. Its portability and real-time analysis capabilities aim to enhance accessibility to ophthalmic care.
5G-Powered Blood Monitoring for Cancer Patients
Partnering with Leuko, Telefónica is integrating 5G and edge computing into the PointCheck system to facilitate non-invasive white blood cell monitoring. By capturing capillary blood flow videos from a patient’s fingertip, the system utilizes AI to detect signs of severe neutropenia. With low-latency 5G transmission, patients can perform the test remotely, minimizing hospital visits and potential infection exposure.
Both innovations will be presented at Telefónica Agora at MWC on March 5 under the session “Technologies for Health: From CatEye to 5G Smart Blood Monitoring and IoT.” These advancements underscore Telefónica’s commitment to enhancing healthcare accessibility, efficiency, and patient outcomes through next-generation connectivity and AI.
Benefit from Massive discount on our 5G Training with 5WorldPro.com
Start your 5G journey and obtain 5G certification
contact us: [email protected]